Compounds > mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin
Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and pyrazolanthrone

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with pyrazolanthrone in 2 studies

Compound Research Comparison

Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Recent Studies (post-2010)
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Studies
(pyrazolanthrone)		Trials
(pyrazolanthrone)		Recent Studies (post-2010) (pyrazolanthrone)
690421,4842765

Protein Interaction Comparison

ProteinTaxonomymn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin (IC50)pyrazolanthrone (IC50)
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C20.2
TPA: protein transporter TIM23Saccharomyces cerevisiae S288C6.31
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)0.72
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)8
Dual specificity protein kinase TTKHomo sapiens (human)0.8987
Mitogen-activated protein kinase 8Homo sapiens (human)0.921
Mitogen-activated protein kinase 9Homo sapiens (human)1.0111
Tyrosine-protein kinase JAK3Homo sapiens (human)0.957
Mitogen-activated protein kinase 10Homo sapiens (human)1.4193
Mitogen-activated protein kinase 14Homo sapiens (human)0.15

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alhosin, M; Anselm, E; Bronner, C; Kim, JH; Madeira, SV; Rashid, S; Schini-Kerth, VB1
Du, Y; Hill, J; Hsiai, TK; Li, R; Navab, M; Pakbin, P; Shen, M; Sioutas, C1

Other Studies

2 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and pyrazolanthrone

ArticleYear
Redox-sensitive up-regulation of eNOS by purple grape juice in endothelial cells: role of PI3-kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Animals; Anthracenes; Antioxidants; Beverages; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Coronary Vessels; Endothelial Cells; Forkhead Transcription Factors; Imidazoles; JNK Mitogen-Activated Protein Kinases; Metalloporphyrins; Nitric Oxide Synthase Type III; Nitrogen Oxides; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pyridines; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Messenger; Swine; Vitis

2013
Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS.
    Biochemical and biophysical research communications, 2013, Jul-05, Volume: 436, Issue:3

    Topics: Acetophenones; Animals; Anthracenes; Aorta; Biomimetics; Cells, Cultured; Cyclic N-Oxides; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Glutathione; Humans; Metalloporphyrins; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Particle Size; Particulate Matter; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1

2013